Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SARS coronavirus detection.

Andreas Nitsche1, Brunhilde Schweiger, Heinz Ellerbrok

  • 1Robert Koch-Institut, Berlin, Germany. nitschea@rki.de

Emerging Infectious Diseases
|August 25, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nipah Virus Shedding in Urine from Fruit Bats, Sri Lanka, 2018-2019.

Emerging infectious diseases·2026
Same author

Reduction in Respiratory Syncytial Virus (RSV)-Related Outpatient and Inpatient Cases Among Infants During the Initial 2024/2025 Season Following Nirsevimab Recommendation in Germany.

Influenza and other respiratory viruses·2026
Same author

Dengue NS1 as a Driver of Immune-Mediated Pathogenesis.

Tropical medicine and infectious disease·2026
Same author

Skin and Wound Infection Models to Test Host-Pathogen Interactions and Evaluate Topical Antimicrobial Treatments.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Rapid spread of MPXV clade Ib with high genetic relatedness among men who have sex with men, Berlin, Germany, week 50 2025 up to week 10 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

First report of pathogenic Leptospira in Sri Lankan bats: A potential reservoir risk?

PLoS neglected tropical diseases·2026
Same journal

Detection of and Early Genomic Insights into Chikungunya Virus, Bolivia, 2025.

Emerging infectious diseases·2026
Same journal

Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022-2024.

Emerging infectious diseases·2026
Same journal

New World Ocular Dirofilariasis Caused by Dirofilaria repens Infection, United States.

Emerging infectious diseases·2026
Same journal

Angiostrongylus cantonensis Rat Lungworm Detected in Rats, Madagascar, 2022-2023.

Emerging infectious diseases·2026
Same journal

Human Pulmonary Dirofilariasis,
North Queensland, Australia, 2023<sup>1</sup>.

Emerging infectious diseases·2026
Same journal

Trends in Congenital Syphilis Cases by Maternal Country of Birth, Spain, 2016-2024.

Emerging infectious diseases·2026
See all related articles

Researchers created three real-time reverse transcription-polymerase chain reaction (PCR) assays for detecting SARS-associated coronavirus (SARS-CoV). These highly sensitive assays can identify less than 10 genome equivalents of SARS-CoV.

Area of Science:

  • Virology
  • Molecular Biology
  • Infectious Diseases

Background:

  • The SARS-associated coronavirus (SARS-CoV) poses a significant public health threat.
  • Accurate and rapid detection of SARS-CoV is crucial for disease control and management.

Purpose of the Study:

  • To develop and validate sensitive real-time reverse transcription-polymerase chain reaction (RT-PCR) assays for SARS-CoV detection.
  • To create assays capable of amplifying multiple regions of the SARS-CoV genome for enhanced reliability.

Main Methods:

  • Development of three distinct real-time RT-PCR assays targeting different regions of the SARS-CoV genome.
  • Optimization of assays for parallel or single-tube usage.
  • Validation of assay sensitivity, detecting down to fewer than 10 genome equivalents of SARS-CoV.

Related Experiment Videos

  • Consideration of all available SARS-CoV sequences for broad applicability.
  • Adaptation of assays for two major real-time PCR platforms.

    • Main Results:

    • Successful development of three highly specific and sensitive real-time RT-PCR assays for SARS-CoV.
    • Demonstrated ability to detect less than 10 genome equivalents of SARS-CoV, indicating high sensitivity.
    • Assays confirmed to work effectively when run in parallel or combined in a single tube.
    • Optimization achieved for compatibility with prominent real-time PCR platforms.

    Conclusions:

    • The developed real-time RT-PCR assays provide a sensitive and reliable tool for SARS-CoV detection.
    • These assays offer flexibility in application, suitable for parallel or single-tube formats.
    • The assays' broad sequence coverage and platform compatibility enhance their utility in diagnostic and research settings.